Atara Biotherapeutics(DE:AT20)
€6.10+0.30 (+5.17%)
DE:AT20
Atara Biotherapeutics earnings date
€6.10
At close:+0.30 (+5.17%)
Atara Biotherapeutics (AT20) Q4 2022 Earnings Report
0 Followers
DE:AT20 Q4 2022 EPS Results
- Actual EPS
- -EUR 16.40
- Consensus EPS
- -EUR 11.84
- Beat/Miss
- Missed by -EUR 4.56
- One Year Ago EPS
- -EUR 21.87
DE:AT20 Q4 2022 Revenue Results
- Actual Revenue
- EUR 201.41K
- Expected Revenue
- EUR 30.99M
- Beat/Miss
- Missed by -EUR 30.79M
- YoY Revenue Growth
- -97.07%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 02/08/2023
- Time
- After Close
- Conference Call
- Wednesday, February 8, 2023
DE:AT20 Upcoming Earnings
Atara Biotherapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:AT20 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.03- | -0.23 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.12-0.14 | -0.29 | 53.13% (+0.15) | |
| Aug 12, 2026 | 2026 (Q2) | -0.29-0.29 | 0.17 | -268.42% (-0.46) | |
| May 12, 2026 | 2026 (Q1) | -0.30-0.26 | 3.19 | -108.29% (-3.45) | |
| Mar 16, 2026 | 2025 (Q4) | -0.16-0.23 | -1.08 | 78.99% (+0.86) | |
| Nov 29, 2025 | 2025 (Q3) | -0.61-0.29 | -2.67 | 89.08% (+2.38) | |
| Aug 11, 2025 | 2025 (Q2) | -0.060.17 | -2.83 | 106.13% (+3.00) | |
| May 15, 2025 | 2025 (Q1) | -1.803.19 | -5.24 | 160.87% (+8.43) | |
| Mar 07, 2025 | 2024 (Q4) | -2.61-1.08 | -12.76 | 91.50% (+11.67) | |
| Nov 12, 2024 | 2024 (Q3) | -1.72-2.67 | -15.04 | 82.24% (+12.37) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


